1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Comparison of imaging metrics in patients with relapsing-remitting and progressive multiple sclerosis

RRMS LesionsPMS LesionsRRMS NAWMPMS NAWMRRMS vs PMS Lesions (P Value)RRMS vs PMS NAWM (P Value)
AVF0.18 ± 0.040.14 ± 0.020.24 ± 0.020.22 ± 0.02.006a.06
MVF0.18 ± 0.030.13 ± 0.030.26 ± 0.020.22 ± 0.03.001a.01a
G-ratio0.72 ± 0.050.78 ± 0.070.67 ± 0.020.68 ± 0.04.13.39
  • a Significance following Bonferroni correction.